We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+35.87%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$211M
AUM Growth
-$31.9M
Cap. Flow
-$83.2M
Cap. Flow %
-39.42%
Top 10 Hldgs %
8.5%
Holding
499
New
89
Increased
112
Reduced
218
Closed
57

Top Buys

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$1.29M
2
WES icon
Western Midstream Partners
WES
+$970K
3
VNOM icon
Viper Energy
VNOM
+$883K
4
CNQ icon
Canadian Natural Resources
CNQ
+$761K
5
EPR icon
EPR Properties
EPR
+$729K

Top Sells

Rank Stock Value
1
BBDC icon
Barings BDC
BBDC
+$2.49M
2
PSEC icon
Prospect Capital
PSEC
+$2.37M
3
BKCC
BlackRock Capital Investment Corporation
BKCC
+$2.34M
4
JQC icon
Nuveen Credit Strategies Income Fund
JQC
+$2.3M
5
WHF icon
WhiteHorse Finance
WHF
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 33.94%
2 Real Estate 15.9%
3 Energy 15.5%
4 Materials 8.79%
5 Financials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBIT icon
251
XBiotech
XBIT
$69.2M
$361K 0.17%
26,340
+8,245
+46% +$116K
QNCX icon
252
Quince Therapeutics
QNCX
$18.9M
$360K 0.17%
39
-7
-15% -$64.1K
MYOK
253
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$360K 0.17%
3,721
-1,662
-31% -$139K
AKRO
254
DELISTED
Akero Therapeutics
AKRO
$359K 0.17%
14,425
-2,632
-15% -$60.1K
YMAB
255
DELISTED
Y-mAbs Therapeutics
YMAB
$359K 0.17%
8,309
-3,023
-27% -$114K
ARNA
256
DELISTED
Arena Pharmaceuticals Inc
ARNA
$359K 0.17%
5,707
-1,943
-25% -$107K
QTTB icon
257
Q32 Bio
QTTB
$467M
$358K 0.17%
1,310
+346
+36% +$92.2K
EFT
258
Eaton Vance Floating-Rate Income Trust
EFT
$284M
$356K 0.17%
31,246
-135,962
-81% -$1.49M
MCI
259
Barings Corporate Investors
MCI
$343M
$356K 0.17%
26,488
-123,493
-82% -$1.64M
RIGL icon
260
Rigel Pharmaceuticals
RIGL
$712M
$356K 0.17%
19,458
+3,334
+21% +$60K
ADAP
261
DELISTED
Adaptimmune Therapeutics
ADAP
$353K 0.17%
+35,241
New +$221K
DCF
262
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$353K 0.17%
46,127
-142,990
-76% -$1.03M
OYST
263
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$352K 0.17%
+12,188
New +$367K
GARS
264
DELISTED
Garrison Capital Inc.
GARS
$351K 0.17%
103,781
-172,681
-62% -$424K
KURA icon
265
Kura Oncology
KURA
$826M
$350K 0.17%
21,479
-2,850
-12% -$41.1K
VKTX icon
266
Viking Therapeutics
VKTX
$3.93B
$348K 0.16%
48,320
+3,100
+7% +$20.6K
VVR icon
267
Invesco Senior Income Trust
VVR
$454M
$347K 0.16%
100,307
-400,492
-80% -$1.36M
RUBY
268
DELISTED
Rubius Therapeutics, Inc
RUBY
$346K 0.16%
+57,793
New +$341K
PRNB
269
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$345K 0.16%
5,775
-1,460
-20% -$90.2K
PRVB
270
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$344K 0.16%
24,401
-6,256
-20% -$79K
ADVM
271
DELISTED
Adverum Biotechnologies
ADVM
$343K 0.16%
1,643
-1,768
-52% -$313K
DNLI icon
272
Denali Therapeutics
DNLI
$3.82B
$343K 0.16%
14,174
-4,846
-25% -$114K
SWTX
273
DELISTED
SpringWorks Therapeutics
SWTX
$342K 0.16%
8,149
-4,299
-35% -$153K
VSTM icon
274
Verastem
VSTM
$547M
$342K 0.16%
+16,584
New +$439K
ICPT
275
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$341K 0.16%
7,119
+1,963
+38% +$152K
9 10
11
12 13

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Virtus ETF Advisers held 499 positions worth $211M, down 13% from $243M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Virtus ETF Advisers withdrew a net $83.2M in Q2 2020, closing 57 positions and reducing 218 holdings. Its most notable exit was Tallgrass Energy, LP Class A Shares, an estimated $1.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 20% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Verastem worth $342K.

  • Virtus ETF Advisers's largest Q2 2020 buy was Verastem: 16,584 shares worth $342K.
  • Virtus ETF Advisers added most to Delek Logistics in Q2 2020, an estimated $1.29M increase.
  • Virtus ETF Advisers's biggest Q2 2020 reduction was Barings BDC, cutting an estimated $2.49M.
  • Virtus ETF Advisers fully exited Tallgrass Energy, LP Class A Shares in Q2 2020, selling an estimated $1.22M.
  • Virtus ETF Advisers's ten largest holdings make up 8.5% of its $211M portfolio in Q2 2020.
  • Virtus ETF Advisers opened 89 new positions and closed 57 in Q2 2020.
  • Virtus ETF Advisers's portfolio value fell 13% quarter-over-quarter to $211M.

Based on Virtus ETF Advisers's 13F filing for Q2 2020, filed 5 Aug 2020.